| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:506525610:1783 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:506525610:1783?format=raw |
LEADER: 01783cam a2200421 a 4500
001 3952058
005 20221027005303.0
008 900808t19901990nyua b 001 0 eng c
010 $a 90003297
020 $a0824782143 (alk. paper) :$c$99.75 (U.S. and Canada)
035 $a(OCoLC)21442620
035 $a(OCoLC)ocm21442620
035 $a(CStRLIN)NYCM90-B2801
035 $9AEQ0351HS
035 $a(NNC)3952058
035 $a3952058
040 $aDNLM/DLC$cDLC$dNNC-M
050 00 $aRC933$b.I43 1990
060 0 $aW1 IN41LA v. 4$aWE 544 I338
082 00 $a616.7/23061$220
245 00 $aImmunomodulators in the rheumatic diseases /$cedited by Daniel E. Furst, Michael E. Weinblatt.
260 $aNew York :$bM. Dekker,$c[1990], ©1990.
300 $ax, 261 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aInflammatory disease and therapy ;$v4
504 $aIncludes bibliographical references.
500 $aIncludes index.
650 0 $aRheumatoid arthritis$xImmunotherapy.
650 0 $aRheumatism$xImmunotherapy.
650 0 $aImmunosuppressive agents.$0http://id.loc.gov/authorities/subjects/sh85064589
650 2 $aAdjuvants, Immunologic$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D000276Q000627
650 2 $aRheumatic Diseases$ximmunology.$0https://id.nlm.nih.gov/mesh/D012216Q000276
650 2 $aRheumatic Diseases$xtherapy.$0https://id.nlm.nih.gov/mesh/D012216Q000628
700 1 $aFurst, Daniel E.,$d1942-$0http://id.loc.gov/authorities/names/n86014174
700 1 $aWeinblatt, Michael E.$0http://id.loc.gov/authorities/names/n85349335
830 0 $aInflammatory disease and therapy ;$v4.$0http://id.loc.gov/authorities/names/n86728770
852 00 $boff,hsl$hRC933$i.I43 1990